Gene therapy for restenosis: Getting nearer the heart of the matter

Sanghong Baek, Keith L. March

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Intensive work over the past decade has been directed to the study of vascular gene transfer as an approach to the unresolved problem of restenosis. This effort has resulted in a significant foundation of knowledge relative to the activities of potentially therapeutic gene products as well as the capabilities and limitations of vector systems and mechanical delivery modalities available for effecting the vascular expression of these gene products. In several instances, significant progress has been made by experiments highlighting unexpected difficulties and the need for more comprehensive understanding. It is thus now possible to clearly define and address specific challenges that must be overcome in order to make feasible progress from the preclinical to the clinical arena. The key challenges at present appear to include the evolution of clinically practical delivery methods that meet the kinetic requirements of achieving efficient gene transduction and the availability of vectors that maximize efficiency while minimizing undesirable host responses. Emerging data suggest that approaches to solving each of these issues may have recently been developed. Basic research evaluating these new delivery mechanisms and molecular vectors is essential to establish their true potential for use in the clinical arena.

Original languageEnglish
Pages (from-to)295-305
Number of pages11
JournalCirculation Research
Volume82
Issue number3
StatePublished - Feb 23 1998

Fingerprint

Genetic Therapy
Blood Vessels
Genes
Gene Expression
Research
Therapeutics

Keywords

  • Gene therapy
  • Local delivery
  • Restenosis
  • Transduction efficiency
  • Vectors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Gene therapy for restenosis : Getting nearer the heart of the matter. / Baek, Sanghong; March, Keith L.

In: Circulation Research, Vol. 82, No. 3, 23.02.1998, p. 295-305.

Research output: Contribution to journalArticle

Baek, S & March, KL 1998, 'Gene therapy for restenosis: Getting nearer the heart of the matter', Circulation Research, vol. 82, no. 3, pp. 295-305.
Baek, Sanghong ; March, Keith L. / Gene therapy for restenosis : Getting nearer the heart of the matter. In: Circulation Research. 1998 ; Vol. 82, No. 3. pp. 295-305.
@article{6abb45ebac3145bfbc2064f5c5447fd9,
title = "Gene therapy for restenosis: Getting nearer the heart of the matter",
abstract = "Intensive work over the past decade has been directed to the study of vascular gene transfer as an approach to the unresolved problem of restenosis. This effort has resulted in a significant foundation of knowledge relative to the activities of potentially therapeutic gene products as well as the capabilities and limitations of vector systems and mechanical delivery modalities available for effecting the vascular expression of these gene products. In several instances, significant progress has been made by experiments highlighting unexpected difficulties and the need for more comprehensive understanding. It is thus now possible to clearly define and address specific challenges that must be overcome in order to make feasible progress from the preclinical to the clinical arena. The key challenges at present appear to include the evolution of clinically practical delivery methods that meet the kinetic requirements of achieving efficient gene transduction and the availability of vectors that maximize efficiency while minimizing undesirable host responses. Emerging data suggest that approaches to solving each of these issues may have recently been developed. Basic research evaluating these new delivery mechanisms and molecular vectors is essential to establish their true potential for use in the clinical arena.",
keywords = "Gene therapy, Local delivery, Restenosis, Transduction efficiency, Vectors",
author = "Sanghong Baek and March, {Keith L.}",
year = "1998",
month = "2",
day = "23",
language = "English",
volume = "82",
pages = "295--305",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gene therapy for restenosis

T2 - Getting nearer the heart of the matter

AU - Baek, Sanghong

AU - March, Keith L.

PY - 1998/2/23

Y1 - 1998/2/23

N2 - Intensive work over the past decade has been directed to the study of vascular gene transfer as an approach to the unresolved problem of restenosis. This effort has resulted in a significant foundation of knowledge relative to the activities of potentially therapeutic gene products as well as the capabilities and limitations of vector systems and mechanical delivery modalities available for effecting the vascular expression of these gene products. In several instances, significant progress has been made by experiments highlighting unexpected difficulties and the need for more comprehensive understanding. It is thus now possible to clearly define and address specific challenges that must be overcome in order to make feasible progress from the preclinical to the clinical arena. The key challenges at present appear to include the evolution of clinically practical delivery methods that meet the kinetic requirements of achieving efficient gene transduction and the availability of vectors that maximize efficiency while minimizing undesirable host responses. Emerging data suggest that approaches to solving each of these issues may have recently been developed. Basic research evaluating these new delivery mechanisms and molecular vectors is essential to establish their true potential for use in the clinical arena.

AB - Intensive work over the past decade has been directed to the study of vascular gene transfer as an approach to the unresolved problem of restenosis. This effort has resulted in a significant foundation of knowledge relative to the activities of potentially therapeutic gene products as well as the capabilities and limitations of vector systems and mechanical delivery modalities available for effecting the vascular expression of these gene products. In several instances, significant progress has been made by experiments highlighting unexpected difficulties and the need for more comprehensive understanding. It is thus now possible to clearly define and address specific challenges that must be overcome in order to make feasible progress from the preclinical to the clinical arena. The key challenges at present appear to include the evolution of clinically practical delivery methods that meet the kinetic requirements of achieving efficient gene transduction and the availability of vectors that maximize efficiency while minimizing undesirable host responses. Emerging data suggest that approaches to solving each of these issues may have recently been developed. Basic research evaluating these new delivery mechanisms and molecular vectors is essential to establish their true potential for use in the clinical arena.

KW - Gene therapy

KW - Local delivery

KW - Restenosis

KW - Transduction efficiency

KW - Vectors

UR - http://www.scopus.com/inward/record.url?scp=0032559627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032559627&partnerID=8YFLogxK

M3 - Article

C2 - 9486657

AN - SCOPUS:0032559627

VL - 82

SP - 295

EP - 305

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 3

ER -